| Preface |
|
vii | |
| Contributors |
|
ix | |
|
Section I, Introduction to Liver Biology |
|
|
|
Liver stem cells in persistent viral infection, liver regeneration and cancer |
|
|
3 | (12) |
|
|
|
|
|
|
|
15 | (18) |
|
|
|
|
|
|
|
Section II, Clinical Aspects of Viral Hepatitis |
|
|
|
Clinical features of hepatitis |
|
|
33 | (17) |
|
|
|
|
|
Diagnostic approach to viral hepatitis |
|
|
50 | (15) |
|
|
|
|
|
|
|
Evolution of hepatitis viruses |
|
|
65 | (14) |
|
|
|
Section III, Hepatitis A Virus |
|
|
|
Structure and molecular virology |
|
|
79 | (13) |
|
|
|
|
|
|
|
92 | (17) |
|
|
|
|
|
Natural history and experimental models |
|
|
109 | (17) |
|
|
|
|
|
|
|
126 | (23) |
|
|
|
Section IV, Hepatitis B Virus and Other Hepadnaviridae |
|
|
|
Structure and molecular virology |
|
|
149 | (32) |
|
|
|
|
|
|
|
181 | (12) |
|
|
|
|
|
193 | (17) |
|
|
|
|
|
Woodchuck hepatitis virus |
|
|
210 | (15) |
|
|
|
|
|
Hepatitis B surface antigen (HBsAg) variants |
|
|
225 | (17) |
|
|
|
|
|
|
|
|
|
|
|
Molecular variations in the core promoter, precore and core regions of hepatitis B virus, and their clinical significance |
|
|
242 | (21) |
|
|
|
|
|
|
|
Natural history of chronic hepatitis B and hepato-cellular carcinoma |
|
|
263 | (6) |
|
|
|
|
|
Hepatocellular carcinoma: molecular aspects in hepatitis B |
|
|
269 | (26) |
|
|
|
Patricia Paterlini-Brechot |
|
|
|
|
|
|
Murine models and hepatitis B virus infection |
|
|
295 | (13) |
|
|
|
Pathogenesis of chronic hepatitis B |
|
|
308 | (15) |
|
|
|
|
|
Treatment of chronic hepatitis B |
|
|
323 | (14) |
|
|
|
|
|
|
|
Management of drug-resistant mutants |
|
|
337 | (8) |
|
|
|
Liver transplantation in the management of chronic viral hepatitis |
|
|
345 | (25) |
|
|
|
|
|
|
|
370 | (11) |
|
|
|
Section V, Hepatitis C Virus |
|
|
|
Structure and molecular virology |
|
|
381 | (26) |
|
|
|
|
|
|
|
407 | (19) |
|
|
|
|
|
The immune response to hepatitis C virus in acute and chronic infection |
|
|
426 | (13) |
|
|
|
|
|
Natural history and experimental models |
|
|
439 | (29) |
|
|
|
|
|
|
|
|
|
468 | (14) |
|
|
|
|
|
Central nervous system complications |
|
|
482 | (14) |
|
|
|
|
|
|
|
|
|
In vitro replication models |
|
|
496 | (15) |
|
|
|
|
|
|
|
511 | (9) |
|
|
|
|
|
|
|
|
|
|
|
The natural history of hepatitis C and hepatocellular carcinoma |
|
|
520 | (6) |
|
|
|
Treatment of chronic hepatitis C |
|
|
526 | (14) |
|
|
|
|
|
New drugs for the management of hepatitis C |
|
|
540 | (13) |
|
|
|
|
|
|
|
|
|
553 | (18) |
|
|
|
|
|
|
|
Section VI, Hepatitis D Virus |
|
|
|
Structure and molecular virology |
|
|
571 | (12) |
|
|
|
Epidemiology and natural history |
|
|
583 | (10) |
|
|
|
|
|
|
|
593 | (10) |
|
|
|
|
|
|
|
Section VII, Hepatitis E Virus |
|
|
|
Structure and molecular virology |
|
|
603 | (8) |
|
|
|
|
|
Hepatitis E as a zoonotic disease |
|
|
611 | (13) |
|
|
|
Epidemiology, clinical and pathologic features, diagnosis, and experimental models |
|
|
624 | (11) |
|
|
|
|
|
|
|
|
|
635 | (16) |
|
|
|
|
|
Section VIII, Clinical Aspects of Viral Liver Disease |
|
|
|
Aetiology of fulminant hepatitis |
|
|
651 | (15) |
|
|
|
|
|
Treatment of fulminant hepatitis |
|
|
666 | (16) |
|
|
|
|
|
|
|
Hepatitis and haemophilia |
|
|
682 | (11) |
|
|
|
Occupational aspects of hepatitis |
|
|
693 | (21) |
|
|
|
|
|
Neonatal and paediatric infection |
|
|
714 | (26) |
|
|
|
|
|
Management of hepatocellular cancer |
|
|
740 | (15) |
|
|
|
|
|
Application of molecular biology to the diagnosis of viral hepatitis |
|
|
755 | (14) |
|
|
|
Hepatitis in HIV-infected persons |
|
|
769 | (11) |
|
|
|
|
|
Treatment of extrahepatic diseases caused by hepatitis B and hepatitis C viruses |
|
|
780 | (14) |
|
|
|
|
|
The histologist's role in the diagnosis and management of chronic hepatitis B and C |
|
|
794 | (10) |
|
|
|
|
|
Disinfection and sterilization |
|
|
804 | (11) |
|
|
|
|
|
Mechanisms of interferon resistance |
|
|
815 | (9) |
|
|
|
|
|
|
|
New in vitro testing systems for hepatitis B and C viruses |
|
|
824 | (17) |
|
|
|
|
|
|
|
|
|
New vaccine technologies and the control of viral hepatitis |
|
|
841 | (10) |
|
|
|
Safety of hepatitis B vaccines |
|
|
851 | (3) |
|
|
|
Before and since the discovery of Australia antigen: a chronological review of viral hepatitis |
|
|
854 | (11) |
|
|
|
|
| Index |
|
865 | |